International Journal of Nanomedicine (Apr 2019)

Glucose-responsive mesoporous silica nanoparticles to generation of hydrogen peroxide for synergistic cancer starvation and chemistry therapy

  • Du X,
  • Zhang T,
  • Ma G,
  • Gu X,
  • Wang G,
  • Li J

Journal volume & issue
Vol. Volume 14
pp. 2233 – 2251

Abstract

Read online

Xiao Du,1 Tian Zhang,1 Guanglan Ma,1 Xiaochen Gu,2 Guangji Wang,3 Juan Li11Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, , People’s Republic of China; 2College of Pharmacy, University of Manitoba, Winnipeg, MB, Canada; 3Center for New Drug Safety Evaluation and Research, China Pharmaceutical University, Nanjing, People’s Republic of ChinaBackground: The combination of novel starving therapy with chemotherapy is one of the most promising strategies to achieve an effective antitumor activity.Methods: Herein, we developed a multifunctional mesoporous silica nanoparticle (MSNs-GOx/PLL/HA) coated with poly (L-lysine) (PLL) and hyaluronic acid (HA) for co-delivery of glucose oxidase (GOx) and anticancer drug paclitaxel (PTX) for cancer treatment for the first time. Compared to single chemotherapy, introduction of GOx would not only selectively trigger the consumption of intracellular glucose, leading to the interruption of energy supply, but also elevat the endogenous H2O2 level, inducing stronger therapeutic effects.Results: The novel drug delivery system possessed desirable particle diameter of 40 nm and exhibited a pH-sensitive drug release behavior. An in vitro cellular uptake study indicated that MSNs-GOx/PLL/HA nanoparticles effectively enhanced the cellular uptake of drug in an apparently CD44 receptor-dependent manner, and delivered more cargo into cytoplasm via endolysosomal escape effect in presence of PLL. The nanoplatform has also demonstrated amplified synergistic therapeutic effects for remarkable tumor inhibition in a xenograft animal tumor model.Conclusion: Consequently, the developed synergistic starving-like/chemotherapy may provide a potential platform for next generation cancer therapy.Keywords: combination therapy, glucose oxidase, hyaluronic acid, pH-sensitivity, nanomedicine

Keywords